Discovery of molecular switch for protein production
en-GBde-DEes-ESfr-FR

Discovery of molecular switch for protein production


LMU scientists show how bacteria control their protein biosynthesis through cell metabolism – possible approach for developing novel therapies.

Protein biosynthesis – the process whereby cells produce protein molecules, which are essential for life and growth – is a highly complex and strictly regulated affair. An interdisciplinary team led by LMU biologist PD Dr. Jürgen Lassak has now discovered a previously unknown mechanism by which bacteria control this process. As the scientists report in the journal Nature Communications, a protein called EfpL functions as a controller that can ramp up or arrest protein production according to the metabolism of the cell.

Incorporating the amino acid building block proline into the nascent protein molecule presents a particular challenge for the cell during protein biosynthesis. Due to its rigid structure, proline frequently causes stalls at ribosomes – the “protein factories” of the cell. All organisms use a specific factor to overcome these stalls. In bacteria, this factor is called EF-P and helps ribosomes incorporate proline. As the researchers have now discovered, some bacteria possess an additional tool for protein biosynthesis – a protein called EfpL, which is closely related to EF-P. In contrast to EF-P, however, this protein reacts to the metabolism of the cell and adapts protein synthesis to the prevailing requirements through specific chemical modifications.

“EfpL offers us a unique opportunity to understand the flexible adaptation of bacterial protein production to environmental conditions,” explains Alina Sieber, lead author of the study. “This type of regulation was previously unknown,” adds Lassak, “and we’ve shown for the first time that the metabolism of the cell influences the activity of EfpL.” It is particularly interesting, he observes, that many human pathogens are found among the bacteria that use EfpL, including Salmonella species and Escherichia coli as well as the pathogens responsible for cholera and the plague.

The authors conjecture that the precise control of protein production by EfpL is an effective adaptation to changing habitats – such as when bacteria enter a human host. Consequently, inhibiting EfpL could offer a promising approach for suppressing the growth of such pathogens and thus developing novel therapeutic strategies.
A. Sieber et al.: EF-P and its paralog EfpL (YeiP) differentially control translation of proline-containing sequences. Nature Communications 2024. https://doi.org/10.1038/s41467-024-54556-9
Regions: Europe, Germany
Keywords: Science, Life Sciences

Disclaimer: AlphaGalileo is not responsible for the accuracy of news releases posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Referenzen

We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet
AlphaGalileo is a great source of global research news. I use it regularly.
Robert Lee Hotz, LA Times

Wir arbeiten eng zusammen mit...


  • BBC
  • The Times
  • National Geographic
  • The University of Edinburgh
  • University of Cambridge
  • iesResearch
Copyright 2024 by DNN Corp Terms Of Use Privacy Statement